Publications (41)

2023

  1. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome

    Kidney International, Vol. 104, Núm. 4, pp. 851-855

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

2019

  1. Uncontrolled donation after circulatory death: A cohort study of data from a long-standing deceased-donor kidney transplantation program

    American Journal of Transplantation, Vol. 19, Núm. 6, pp. 1693-1707

2016

  1. Antibody-Mediated Acute Vascular Rejection of Kidney Allografts: Fifteen-Year Follow-up

    Transplantation Proceedings, Vol. 48, Núm. 9, pp. 2917-2919

  2. Presence of T-275A and C-2152T Polymorphisms of the Promoter Region of Uridine Diphosphate-Glucuronosyltransferase 1A9 Increases Mortality From Digestive Tumors: Results After 10 Years of Follow-up in a Renal Transplant Population

    Transplantation Proceedings, Vol. 48, Núm. 9, pp. 2947-2949

  3. Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants

    Transplantation Proceedings, Vol. 48, Núm. 9, pp. 2956-2958

  4. Whooping cough in a renal transplant recipient

    Transplant Infectious Disease, Vol. 18, Núm. 2, pp. 280-283

2015

  1. Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant Recipients

    American Journal of Transplantation, Vol. 15, Núm. 5, pp. 1323-1335

2013

  1. The impact of darbepoietin alfa in early post-transplant anaemia management: Retrospective exploratory study

    Nefrologia, Vol. 33, Núm. 1, pp. 107-115

2012

  1. Everolimus as primary immunosuppression in kidney transplantation: Experience in conversion from calcineurin inhibitors

    Transplantation, Vol. 93, Núm. 4, pp. 398-405

  2. Limited-sampling strategy for mycophenolic acid in renal transplant recipients reciving enteric-coated mycophenolate sodium and tacrolimus

    Therapeutic Drug Monitoring, Vol. 34, Núm. 3, pp. 298-305

  3. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation

    Transplantation Proceedings

  4. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 11, pp. 4227-4235

2011

  1. Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis

    Alimentary Pharmacology and Therapeutics, Vol. 33, Núm. 2, pp. 275-284

  2. Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients

    Transplant Infectious Disease, Vol. 13, Núm. 6, pp. 584-591

2010

  1. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: Pharmacodynamic and microbiological aspects

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 2, pp. 103-108

  2. Candiduria in renal transplant recipients: Incidence, clinical repercussion, and treatment indication

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2944-2946

  3. Early statin use is an independent predictor of long-term graft survival

    NDT Plus, Vol. 3, Núm. SUPPLL. 2

  4. Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2902-2904

2009

  1. Graft Outcome and Mycophenolic Acid Trough Level Monitoring in Kidney Transplantation

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2102-2103